Cargando…
Acquired thrombotic thrombocytopenic Purpura diagnosed during first trimester of pregnancy with excellent outcome after plasma exchange and rituximab, a case report
Acquired thrombotic thrombocytopenic purpura is a life‐threatening condition that rarely presents during pregnancy. Early diagnosis and treatment with plasma exchange is needed to achieve a good pregnancy outcome.
Autores principales: | Arzuaga‐Mendez, Javier, Moreno, Maite, Mateos‐Mazón, Juan J., Vara, Miriam, Dueñas, Marta, Del Orbe, Rafael A., Amutio, Elena, Arrizabalaga, Beatriz, García‐Ruiz, Juan C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981779/ https://www.ncbi.nlm.nih.gov/pubmed/33768832 http://dx.doi.org/10.1002/ccr3.3752 |
Ejemplares similares
-
Thrombotic thrombocytopenic purpura in the first trimester of pregnancy
por: Sikka, Pooja, et al.
Publicado: (2013) -
Successful treatment of plasma exchange-refractory thrombotic thrombocytopenic purpura with rituximab: A case report
por: Chen, Jian, et al.
Publicado: (2020) -
Thrombotic thrombocytopenic purpura treated with rituximab in systemic lupus erythematosus
por: Karimifar, Mansoor
Publicado: (2012) -
Rituximab as first-line treatment for acquired thrombotic thrombocytopenic purpura
por: Chen, Haifei, et al.
Publicado: (2017) -
Refractory Thrombotic Thrombocytopenic Purpura to Therapeutic Plasma Exchange
por: Kiamos, Amy, et al.
Publicado: (2022)